Daniel T. Mamah, M.D., M.P.E.
Name, Degree: Daniel Mamah, M.D., M.P.E.
Role(s) in Task Force and Work Group: Member, DSM-V Task Force
Institutional Affiliation(s): Washington University
City, State: St. Louis, MO
Biographical Sketch:
Member, DSM-V Task Force
Postdoctoral Research Scholar/Instructor in Psychiatry, Department of Psychiatry, Washington University in St. Louis
St. Louis, MO
Dr. Mamah is on the clinical faculty of the department of psychiatry, Washington University in St. Louis, Missouri, and he is a National Institute of Mental Health postdoctoral fellow in psychiatric epidemiology and biostatistics.
Dr. Mamah’s current research is focused on structural neuroimaging at Washington University’s Conte Center for the Neuroscience of Mental Disorders. Imaging techniques used include semi-automated computerized mapping methods (including Large Deformation-High Dimensional Brain Mapping) to evaluate volume and shape of various neuroanatomical structures, and Diffusion Tensor Imaging to study white matter tracts in individuals with schizophrenia and their healthy relatives, as well as those with other psychiatric disorders. He also studies the clinical and cognitive relationships of various neuroanatomical variables.
Dr. Mamah received his medical degree from the Semmelweis University of Medicine in Budapest, Hungary after graduating from the Federal Government College in Port Harcourt, Nigeria. Following medical school, he spent two years conducting laboratory research at Northwestern University and the Psychiatric Institute of the University of Illinois at Chicago. Dr. Mamah completed his psychiatry residency at Washington University in St. Louis, where he also received a master of psychiatric epidemiology (M.P.E.) degree.
Uncompensated affiliations with non-profit or advocacy organizations that may have a direct or indirect interest in psychiatric diagnosis, treatment, or the DSM-V : Three calendar years before nomination and Each year thereafter through the present calendar year. (For 2008, activities to date and commitments for remainder of year.)
|
Non-Profit and Advocacy Organizations |
Year(s) |
Role |
|
Eastern Missouri Psychiatric Society (an APA District Branch) |
2003-2008 |
9 (Member, Executive Council) |
The two tables below represent Dr.Mamah’s disclosure of significant interests and affiliations for: (1) The time period including the 3 years prior to nomination to serve on the DSM-V Task Force; the calendar year in which nomination to the Task Force occurred; through the calendar year in which the nomination was approved; and (2) the time period including the calendar year after approval, and each successive year to the present.
Dr. Mamah has agreed that, from the time of approval through the publication of DSM-V, projected in 2012, his aggregate annual income derived from industry sources (excluding unrestricted research grants) will not exceed $10,000 in any calendar year.
|
KEY NUMBER:
1. Consultation Fees (include scientific advisory boards)
2. Full- or Part-time Employee
3. Industry-related Grant-Research Support received or pending
4. Honoraria (includes Speakers’ Bureau)
5. Stock or other financial options |
6. Expert testimony
7. Royalties (including right to share of revenue or profit from pharmaceutical, device or other development or product)
8. Patents received or pending
9. Officer, director/trustee, executive (specify)
10. Other (specify) |
Disclosure of significant interests including: Three (3) calendar years before nomination, the calendar year of nomination, through the calendar year of approval to serve on the DSM-V Task Force
|
Commercial or Other Organization |
Year(s) |
Key #(s) |
|
None |
n/a |
n/a |
Disclosure of significant interests Beginning with the calendar year after APA Board of Trustees approval to serve on the DSM-V Task Force, to the present. (For 2008, activities to date and commitments for remainder of year.)
|
Commercial or Other Organization |
Year(s) |
Key #(s) |
|
Foundation for the National Institutes of Health |
2007, 2008 |
3 |
|
Eli Lilly & Co. |
2007, 2008 |
3 |